![](/img/cover-not-exists.png)
Results of the APML3 trial incorporating all-trans-retinoic acid and idarubicin in both induction and consolidation as initial therapy for patients with acute promyelocytic leukemia
Iland, H., Bradstock, K., Seymour, J., Hertzberg, M., Grigg, A., Taylor, K., Catalano, J., Cannell, P., Horvath, N., Deveridge, S., Browett, P., Brighton, T., Chong, L., Springall, F., Ayling, J., CatVolume:
97
Language:
english
Journal:
Haematologica
DOI:
10.3324/haematol.2011.047506
Date:
February, 2012
File:
PDF, 397 KB
english, 2012